Podcasts

Aziz Nazha, MD, former hem/onc at Cleveland Clinic, self-taught computer science expert, and now practice manager in the Data and Machine Learning Team at Amazon Web Services, joins the show to discuss artificial intelligence (AI) and machine learning from an entirely unique perspective. He details the pitfalls of unstructured healthcare data, privacy and ownership issues

Chadi is joined by Priya Sampathkumar, MD, infectious disease specialist and hospital epidemiologist, Mayo Clinic, to detail the COVID vaccine effort over the past 12 months and how the currently approved ones came to be safe and effective in such a short period of time. She then compares each vaccine in relation to their clinical

Andrew Foy, MD, cardiologist at Penn State University, joins the show to discuss publishing bias for medical research along with the psychological dilemma as a result of the pandemic of sacrificing personal liberties for the safety of others. The conversation pivots to Dr. Foy’s experience with boxing at a young age and how he eventually

Toni Choueiri, MD, Dana-Farber Cancer Institute, joins the show to guest host a discussion with Rana McKay, MD, UC San Diego, and Alicia Morgans, MD, MPH, Northwestern University, on the practice-changing abstracts presented at the 2020 ASCO-GU virtual meeting. The trio weigh the importance and real-world implications of the ACIS study for mCRPC, EV-301 for

Chadi welcomes back Jack West, MD, associate clinical professor and medical oncologist, City of Hope Comprehensive Cancer Center, and Nathan Pennell, MD, PhD, thoracic medical oncologist, director of the thoracic oncology program and director of clinical research, Cleveland Clinic, to the show. The task was to break down the ADAURA trial again, but to go

David Fajgenbaum, MD, MBA, MSc, assistant professor in the department of medicine at the University of Pennsylvania, as well as the associate director of patient impact for the Penn Orphan Disease Center, joins the show to talk about his experience writing and receiving feedback on the national bestseller “Chasing My Cure” as a survivor of Castleman disease – a commentary on how he turned hope into action and discovered an old drug that had never been researched in Castleman disease into a personal life-saver.

Vincent Rajkumar, MD, hematologist at the Mayo Clinic (Rochester, MN), joins the show to guest host a debate between Sagar Lonial, MD, FACP, chief medical officer of Winship Cancer Institute of Emory University, and Rafael Fonseca, MD, interim director of Mayo Clinic Cancer Center. These multiple myeloma “gurus” dive into imaging, smoldering disease, endpoints, maintenance,

Tanios S. Bekaii-Saab (@GIcancerDoc), MD, professor of medicine and director of the GI oncology program at the Mayo Clinic (Phoenix, AZ), joins the show to highlight the research with significant clinical application presented at the virtual ASCO-GI meeting, including KEYNOTE-177 and ATOMIC in colorectal cancer, atezolizumab plus bevacizumab for first-line HCC, a survival update in the POLO trial and utility of radiation for pancreatic cancer, PD-1 inhibitors for first-line and adjuvant treatment of gastric cancer, and much more.